Andrew Martin is inaugural Professor of Innovative Clinical Trials and leads the University of Queensland’s cLinical Trials cApability (ULTRA) program. Previously, Andrew was Professor in the biostatistics group at the NHMRC Clinical Trials Centre University of Sydney. Prior to academia (i.e., <2009Q2), Andrew held senior biostatistics roles within research-based pharmaceutical organisations (Pfizer and Roche).
UQ Researcher Profile with grants and research outcomes here https://researchers.uq.edu.au/researcher/42729
研究方向
Prostate Cancer Treatment and ResearchRadiopharmaceutical Chemistry and ApplicationsProstate Cancer Diagnosis and TreatmentCancer survivorship and careGastric Cancer Management and Outcomes
